This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Methodological Issues in a Study of Long-Term Maintenance Therapy With Quetiapine Versus Haloperidol Decanoate

Babatunde Adetunji, MD; Biju Basil, MD; Maju Mathews, MD, MRCPsych; Adedapo Williams, MD; Thomas Osinowo, MD, MS

Published: March 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We would like to comment on the recently published study comparing long-term maintenance therapy of quetiapine with haloperidol decanoate in patients with schizophrenia and schizoaffective disorders.1 On the basis of that study’s poor methodological design and inadequate statistical computations, we wonder how the authors could arrive at any valid conclusion. Comparing an oral atypical antipsychotic (quetiapine) with an intramuscular conventional antipsychotic in an open-labeled design could skew the favorability bias toward quetiapine, especially in terms of reported side effects and efficacy.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 67

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...